Why a diabetes drug fell short of anticancer hopes

Population and animal studies suggested it could treat cancer, but the clinical trials were a bust. Here’s what happened and what potential may remain.

  Science/Technology   Oct 19, 2024   0   36  Add to Reading List
Why a diabetes drug fell short of anticancer hopes

Population and animal studies suggested it could treat cancer, but the clinical trials were a bust. Here’s what happened and what potential may remain.

Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow